Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Sionna Therapeutics, Inc. (SION)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 44,090,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile  


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 3,470,000 3,470,000 3,470,000
Total Buy Value $0 $62,460,000 $62,460,000 $62,460,000
Total People Bought 0 6 6 6
Total Buy Transactions 0 6 6 6
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2025-03-16 2024-12-13 2024-06-14 2023-06-15

   
Records found: 18
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Winkelried Jon 10% Owner   –       –       •   2025-02-10 4 B $18.00 $20,250,000 I/I 1,125,000 6,684,962 1.5     -
   Winkelried Jon 10% Owner   –       –       •   2025-02-10 4 A $0.00 $0 I/I 4,875,547 5,559,962     -
   Shah Rajeev M. Director   –       •       •   2025-02-10 4 B $18.00 $20,250,000 I/I 1,125,000 2,324,498 2.25     -
   Shah Rajeev M. Director   –       •       •   2025-02-10 4 A $0.00 $0 I/I 7,951,493 327,808     -
   Atlas Venture Associates Opportunity Ii, Llc   –       –       •   2025-02-10 4 B $18.00 $1,080,000 I/I 60,000 807,727 0.01     -
   Atlas Venture Associates Opportunity Ii, Llc   –       –       •   2025-02-10 4 A $0.00 $0 I/I 747,727 747,727     -
   Atlas Venture Associates Opportunity Ii, Llc   –       –       •   2025-02-10 4 A $0.00 $0 D/D 2,886,293 2,886,293     -
   Orbimed Capital Gp Viii Llc Director   –       •      –    2025-02-10 4 B $18.00 $9,900,000 I/I 550,000 3,704,959 2.1     -
   Orbimed Capital Gp Viii Llc Director   –       •      –    2025-02-10 4 A $0.00 $0 I/I 3,154,959 3,154,959     -
   Booth Bruce   –       •      –    2025-02-10 4 B $18.00 $1,080,000 I/I 60,000 807,727 0.01     -
   Booth Bruce   –       •      –    2025-02-10 4 A $0.00 $0 I/I 3,634,020 747,727     -
   Thompson Peter A   –       •      –    2025-02-10 4 B $18.00 $9,900,000 I/I 550,000 3,704,959 0.01     -
   Thompson Peter A   –       •      –    2025-02-10 4 A $0.00 $0 I/I 3,154,959 3,154,959     -
   Shah Rajeev M. Director   –       •       •   2025-02-06 3 IO $0.00 $0 I/I 0 1,368,829     -
   Winkelried Jon 10% Owner   –       –       •   2025-02-06 3 IO $0.00 $0 I/I 0 684,415     -
   Ridloff Elena CFO & Head of Corp. Dev.   •       –      –    2025-02-06 3 IO $0.00 $0 D/D 0 123,532     -
   Cloonan Michael President & CEO   •       •      –    2025-02-06 3 IO $0.00 $0 D/D 0 547,343     -
   Mckee Charlotte Chief Medical Officer   •       –      –    2025-02-06 3 IO $0.00 $0 D/D 0 28,415     -

  18 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed